SARS CoV-2

Dyonmed SA., the first Greek company with POINT OF CARE tests and procedures, innovates again and introduces:

DyonCovid19-S texts

Immunity’s evaluation  |  Direct control  |  Suitable for population control

Immunity’s evaluation

Direct control

Suitable for population control

SARS-CoV-2 IgM/IgG Antibody Rapid Test Device (IMMUNOCHROMATOGRAPHY)

Detection of “passive” & “active” immunization.

The kit DyonCovid19-S® is used to detect the IgM and IgG antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human serum, plasma or whole blood sample qualitatively. It is to be used as an aid in the diagnosis of coronavirus infection disease (COVID19), which is caused by SARS-CoV-2 (passive immunization).

The kit DyonCovid19-S ® is used to detect the “Neutralizing antibodies” (nAbs) of the specific spike (S) protein of the surface of SARS COV-2, helping significantly in the diagnosis of “active” immunization (after
vaccination).

 

INTENDED USE

It is used to detect the IgM and IgG antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human serum, plasma or whole blood sample qualitatively.

PERFORMANCE CHARACTERISTICS

Find the patient profile you are interested in

Learn more about

Easy to use | High accuracy | Fast result

Find the patient profile you are interested in

Contact us for further information.

Customer service call center +31 210 6655494

     

I’m interested inDyonCOVID19-S®

Privacy Policy

11 + 6 =